West Midlands Renal Peer Review

Slides:



Advertisements
Similar presentations
Essentials of CKD Comorbidities and outcomes in CKD.
Advertisements

UK Renal Registry 16th Annual Report Figure Data completeness for key variables, stratified by first modality HD = haemodialysis; PD = peritoneal.
World population: 6.7 billion Global Prevalence Patients per million population (p.m.p.) Global View of ESRD Patients World population 1.2% ESRD~ 7% Haemodialysis7-8%
The future of haemodialysis in the UK RCP advanced medicine 2013 Cormac Breen Consultant Nephrologist Guy's and St Thomas' Hospitals London.
UK Renal Registry 17th Annual Report Figure Data completeness for key variables, stratified by first modality DOB = date of birth; PRD = primary.
UK Renal Registry 15th Annual Report Figure One year death rate per 1,000 patient years by UK country and age group for prevalent dialysis.
HAEMODIALYSIS CHAPTER 5. © ANZDATA Registry Figure 5.1 Stock and Flow of Haemodialysis Patients Australia Patients new.
UK Renal Registry 16th Annual Report Figure 8.1. Trend in 1 year after 90 day incident patient survival by first modality, 2005–2011 cohort (adjusted to.
UK Renal Registry 16th Annual Report Figure Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2012.
UK Renal Registry 14th Annual Report Figure 8.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2010.
UK Renal Registry 17th Annual Report Figure 8.1. Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
Vascular access The KidneyCare Audit. The challenge of vascular access – Renal National Service Framework Standard 3 “All children, young people and adults.
© ANZDATA Registry Method and Location of Dialysis 1453 (30%) 632 (13%) 1317 (27%) 1335 (27%) Number of Patients Australia 31-Dec-96.
Scottish Renal Registry Report 2009 Published by the Information Services Division (ISD Scotland), Common Services Agency for NHSScotland, 1 South Gyle.
UK Renal Registry 17th Annual Report Figure 2.1. Prevalence rates per million population by age group and UK country on 31/12/2013.
UK Renal Registry 10th Annual Report 2007 Fig 3.1 Incident rates in the countries of the UK:
Kevan Polkinghorne Aarti Gulyani Stephen McDonald Kylie Hurst CHAPTER 5 HAEMODIALYSIS (including home haemodialysis) 2012 Annual Report—35th Edition ANZDATA.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 21 st MDTR Report 2013, NRR.
ANZDATA Registry Overview Dr Graeme Russ Darwin September 2001 September 2001.
UK Renal Registry 17th Annual Report Figure 1.1. RRT incidence rates in the countries of the UK 1990–2013.
UK Renal Registry 10th Annual Report 2007 Fig 8.1 Median haemoglobin for incident dialysis patients at start of dialysis treatment.
© ANZDATA Registry Method and Location of Dialysis (31%) 634 (12%) 1396 (26%) 1523 (28%) Number of Patients Australia 30-Sep-98 METHA.BRIS98.
Chapter 12 End Stage Kidney Disease among Indigenous Peoples of Australia and New Zealand 2014 ANZDATA Registry 37th Annual Report Data to 31-Dec-2013.
UK Renal Registry 15th Annual Report Figure 6.1. Median haemoglobin for incident dialysis patients at start of dialysis treatment in 2011.
Serum Aluminium monitoring in 16,530 dialysis patients in England and Wales: compliance with national guidelines? Udaya P Udayaraj 1, E J Lamb 2, R.Steenkamp.
Home Haemodialysis in Wales An Evaluation of Nutritional Needs Harriet Williams Clinical Dietitian - Renal Lead, BCU.
UK Renal Registry 16th Annual Report Figure Percentage of haemodialysis patients with phosphate within the range specified by the RA clinical audit.
BBV in Wales Renal Units: a focus on prevention of Hepatitis B infection in dialysis unit M Kumwenda on behalf of the Welsh Audit Group Cardiff
UK Renal Registry 17th Annual Report Figure Box and whisker plot of renal centres’ MRSA rates per 100 dialysis patient years by reporting year.
UK Renal Registry 16th Annual Report Figure Box and whisker plot of MRSA rates by renal centre per 100 prevalent dialysis patients per year by reporting.
Chapter 1 ALL RENAL REPLACEMENT THERAPY IN MALAYSIA
SELF CARE HAEMODIALYSIS PROGRAM ME.  Self Care project outline Haemodialysis patient education programme, in managing renal failure and dialysis procedure.
UK Renal Registry Update 2010 and future plans. Chris Maggs Deputy Director.
UK Renal Registry 10th Annual Report 2007 Fig 9.1 Annual change in percentage of dialysis patients with serum phosphate < 1.8mmol/L and ≥1.1 -≤1.8mmol/L.
CHAPTER 2 DIALYSIS IN MALAYSIA Goh Bak Leong Lim Yam Ngo Ong Loke Meng Ghazali Ahmad Lee Day Guat Source: 20 th MDTR Report 2012, NRR.
Chronic Haemodialysis therapy in octogenarians with ESRF: demographics and outcomes from a single centre in England Dr Punit Yadav Dr Jyoti Baharani.
Home haemodialysis at QEHB.. Overview of the programme Introduction of button hole needling The future.
UK Renal Registry 18th Annual Report
West Midlands Renal Peer Review
West Midlands Renal Peer Review
Shared Haemodialysis Care: Giving people who receive dialysis the opportunity to take a role in their own care. Professor Martin Wilkie – Consultant Renal.
Fig 7.1 Median URR achieved in each renal unit
South West Home Therapies Conference
UK Renal Registry 16th Annual Report
UK Renal Registry 9th Annual Report 2006
Infrared Therapy Treatment for Arterio Venous Fistula
Integrating Health and Social Care
2013 Annual Report - 36th Edition
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 19th Annual Report
Peer Review Oct 2017 Haemodialysis Graphs.
Managing Access by Generating Improvements in Cannulation
North west Regional Day
CHAPTER 1 All Renal Replacement Therapy In Malaysia
Numbers X access units Categories Incentre HD Home hd PD.
Vascular Access Data Session North West Regional Day
CHAPTER 10 Hepatitis on Dialysis
UK Renal Registry 13th Annual Report
West Midlands Renal Peer Review
UK Renal Registry 14th Annual Report
UK Renal Registry 16th Annual Report
ANZDATA Registry 41st Annual Report Highlights of End Stage Kidney Disease in Australia and New Zealand Data to 31-Dec-2017.
UK Renal Registry 14th Annual Report
UK Renal Registry 14th Annual Report
Fig 7.1 Median URR achieved in each centre, 2006
UK Renal Registry 10th Annual Report 2007
UK Renal Registry 16th Annual Report
Stock and Flow of Haemodialysis Patients Australia
ANZDATA: Vascular Access
Stock and Flow of Haemodialysis Patients Australia
Presentation transcript:

West Midlands Renal Peer Review Data Overview

Haemodialysis

1. Number of prevalent patients on chronic HD programme at end of Dec 2016

3. Access numbers – Prevalent in-centre chronic in-centre HD patients dialysing using AVF / AVG. July-Dec 2016

4. Access numbers / percentage for all HD starters and at 3 months (in CKD standards)

5. Bacteraemia rates for all chronic HD population 2016 (including home HD)

5. Bacteraemia rates for all chronic HD population 2016 (including home HD)

6. Non attendance and shortened dialysis times (spot audit for one month) Prescription <12 hrs per week

6. Non attendance and shortened dialysis times (spot audit for one month) Shortened Sessions

6. Non attendance and shortened dialysis times (spot audit for one month) DNA

7. BBV policy: spot audit for patients on chronic HD programme Dec16 using data July- Dec 16 (including home HD)

7. BBV policy: spot audit for patients on chronic HD programme Dec16 using data July- Dec 16 (including home HD), Holiday returner sessions

7. BBV policy: spot audit for patients on chronic HD programme Dec16 using data July- Dec 16 (including home HD), Immunity

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.